NCT07108374

Brief Summary

Evidence demonstrates that the risks of red blood cell transfusions outweigh benefits in many patients who are hospitalized in the pediatric intensive care unit with increased risk of organ dysfunction, infection, delirium, and death. Recommendations have been developed to restrict transfusion in patients who are unlikely to benefit; however, these recommendations have not been consistently adopted into clinical practice. This study examines use of targeted efforts (implementation strategies) to improve implementation of the recommendations, with a goal of reducing unnecessary transfusions and improving patient outcomes in critically ill children.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
9mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Nov 2024Feb 2027

Study Start

First participant enrolled

November 30, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 27, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 7, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

August 7, 2025

Status Verified

July 1, 2025

Enrollment Period

2.1 years

First QC Date

June 27, 2025

Last Update Submit

July 30, 2025

Conditions

Keywords

Red blood cell transfusionsPediatric critical care medicineImplementation ScienceClinical Recommendations

Outcome Measures

Primary Outcomes (1)

  • Mean change from baseline in transfusion recommendation adherence at 18 months (evidence-based threshold alert)

    The investigators will assess the mean rate of nonadherent transfusions at monthly intervals in the pre- (12 months prior to CCDS tool initiation) and post-implementation period (18 months following CCDS tool initiation).

    18 months

Secondary Outcomes (2)

  • Mean change from baseline in transfusion recommendation adherence at 18 months (transfusions that require clinical judgement)

    18 months

  • Reach of computerized clinical decision support (CCDS) tools

    18 months

Other Outcomes (17)

  • Unintended consequences of CCDS tools - Surveys - 6 months

    Provider surveys at 6 months post-CCDS implementation

  • Unintended consequences of CCDS tools - Surveys - 12 months

    Provider surveys at 12 months post-CCDS implementation

  • Unintended consequences of CCDS tools - Interviews 6 months

    Provider surveys and interviews at 6 months post-CCDS implementation

  • +14 more other outcomes

Interventions

Five implementation strategies will be employed in this study to enhance use of the blood transfusion recommendations. These include 1) building consensus, 2) provider education, 3) identifying and empowering champions ,4) use of computerized clinical decision support tools, and 5) provide quantitative metric-based feedback. Strategies 1-3 will occur prior to initiation of CCDS tools. All patients admitted to the PICU following the date of CCDS tool initiation will be considered to be part of the post-implementation phase. The investigators will collect data from the EHR on CCDS use and conduct provider surveys and interviews following CCDS tool initiation. Surveys and interviews will be both be conducted at 6 and 12 months post-CCDS tool initiation. Process and outcomes measures will be assessed before an after use of the implementation strategies.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Employed at Lucile Packard Children's Hospital at Stanford University or the Children's Hospital of Philadelphia AND
  • Employed in one of the following roles:
  • PICU nurse
  • PICU attending
  • PICU fellow
  • PICU resident
  • PICU advanced practice provider
  • Other physician or surgeon in subspecialties whose patients regularly receive transfusions in the PICU
  • PICU TRIP implementation team member
  • PICU nursing leader
  • PICU physician leader
  • Bood bank leader.

You may not qualify if:

  • Unwilling to participate
  • Directly report to the primary investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Lucile Packard Children's Hospital, Stanford University

Palo Alto, California, 94304, United States

Location

The Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: This study is best characterized as an interventional prospective cohort study. The investigators will deploy 5 implementation strategies intended to increase use of the red blood cell transfusion recommendations in two pediatric intensive care units. While all strategies will all be used, the investigators anticipate that implementation of the Computerized Clinical Decision Support (CCDS) tools will pose the greatest operational challenges in future studies and thus the focus of this study is on the implementation evaluation of these CCDS tools using an implementation framework (RE-AIM) customized for clinical informatics interventions. The investigators will prospectively evaluate the CCDS tools using the RE-AIM framework using a mixed methods approach that includes data collection from the Electronic Health Record (EHR) based on CCDS use, provider surveys, and data from brief, focused provider interviews.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor, School of Medicine, Department of Pediatrics, Division of Pediatric Critical Care Medicine

Study Record Dates

First Submitted

June 27, 2025

First Posted

August 7, 2025

Study Start

November 30, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

August 7, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Because PEDSnet is not a public data repository, individual-level datasets are not typically released publicly outside of the network. Due to the complexity and privacy concerns associated with electronic health record data, certified PEDSnet data scientists lead the execution of all data analyses. While the data generated for this study cannot be shared publicly, our study team will make every effort to assist interested investigators and teams in leveraging the PEDSnet network to collaborate to obtain the entire dataset from this study or subset of data necessary for conducting secondary analyses or in answering a new, intended study question. Our study team will provide a final report(s) on our research findings and the investigators will relate that data can be made available for subsequent analyses through PEDSnet and provide necessary contact information to submit a Collaboration Request through PEDSnet or Dr. Steffen.

Locations